These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27524185)

  • 1. [Comparison between micafungin and caspofungin for the empirical treatment of severe intra-abdominal infections in surgical intensive care patients].
    Yan T; Li SL; Wang DX
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2301-6. PubMed ID: 27524185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
    BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
    Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
    JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.
    Senn L; Eggimann P; Ksontini R; Pascual A; Demartines N; Bille J; Calandra T; Marchetti O
    Intensive Care Med; 2009 May; 35(5):903-8. PubMed ID: 19172247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.
    Knitsch W; Vincent JL; Utzolino S; François B; Dinya T; Dimopoulos G; Özgüneş İ; Valía JC; Eggimann P; León C; Montravers P; Phillips S; Tweddle L; Karas A; Brown M; Cornely OA
    Clin Infect Dis; 2015 Dec; 61(11):1671-8. PubMed ID: 26270686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin versus micafungin in the incidence of hepatotoxicity in patients with normal to moderate liver failure.
    Shibata Y; Hagihara M; Kato H; Kawasumi N; Hirai J; Nishiyama N; Asai N; Koizumi Y; Yamagishi Y; Matsuura K; Mikamo H
    J Infect Chemother; 2017 Jun; 23(6):349-353. PubMed ID: 28431933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis.
    Kohno S; Izumikawa K; Yoshida M; Takesue Y; Oka S; Kamei K; Miyazaki Y; Yoshinari T; Kartsonis NA; Niki Y
    Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):387-97. PubMed ID: 23052987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK.
    Sidhu MK; van Engen AK; Kleintjens J; Schoeman O; Palazzo M
    Curr Med Res Opin; 2009 Aug; 25(8):2049-59. PubMed ID: 19575628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication.
    Vekeman F; Weiss L; Aram J; Ionescu-Ittu R; Moosavi S; Xiao Y; Cheng WY; Bhak RH; Tawadrous M; Capparella MR; Montravers P; Duh MS
    BMC Infect Dis; 2018 Aug; 18(1):438. PubMed ID: 30157797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay.
    Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
    Rev Iberoam Micol; 2016; 33(4):196-205. PubMed ID: 27422492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.
    Yamada SM; Tomita Y; Yamaguchi T; Matsuki T
    J Med Case Rep; 2016 Nov; 10(1):316. PubMed ID: 27821139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study.
    Shalhoub S; Wang L; Ching A; Husain S; Rotstein C
    Can J Infect Dis Med Microbiol; 2014; 25(6):299-304. PubMed ID: 25587291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patients treated with micafungin during their stay in intensive care unit].
    Álvarez-Lerma F; Grau S; López C; Jiménez JD; Trasmonte MV; Nieto M; Parra G; Herrero E;
    Med Intensiva; 2015 Nov; 39(8):467-76. PubMed ID: 25798955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
    Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
    Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis.
    Neoh CF; Liew D; Slavin MA; Marriott D; Chen SC; Morrissey O; Stewart K; Kong DC
    Intern Med J; 2013 Jun; 43(6):668-77. PubMed ID: 23461421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.